Background/Aim: The relationship between body mass index (BMI) and intradialytic hypotension (IDH) has been inconsistently reported, but no further research has investigated the correlation between body composition and IDH so far. This study aimed to determine whether the lean tissue index (LTI), fat tissue index (FTI), or both derived from body composition monitoring (BCM) is associated with IDH defined as a nadir intradialytic systolic blood pressure of <90 mm Hg and ≥3 episodes hypotension per 10 hemodialysis (HD) treatments in patients undergoing prevalent HD. Methods: The observational cohort study comprised 1,463 patients receiving thrice-weekly HD from 13 dialysis centers. LTI and FTI were assessed using a BCM machine, a multifrequency bioimpedance spectroscopy device. Unadjusted and multivariable adjusted logistic regression models were fit to estimate the association of body composition with the odds of developing IDH. Results: One hundred and seven patients (7.3%) were diagnosed as IDH. The difference in dialysis vintage, BMI, FTI, LTI, high-density lipoprotein cholesterol, and C-reactive protein between IDH and non-IDH groups was statistically significant (all p < 0.05). The prevalence of diabetes among IDH patients was slightly higher than among non-IDH patients. In logistic regression models, low LTI and high FTI, but not high BMI were associated with greater odds of IDH (“high” as above median and “low” as below median). When patients were further stratified into 4 distinct body composition groups based on both the LTI and FTI, only the low LTI/high FTI group was connected with a significantly higher odds of IDH (OR 2.686, 95% CI 1.072–6.734; reference: low LTI/low FTI group). Conclusions: The LTI and FTI can provide better correlation of IDH occurrence than the BMI alone in prevalent HD patients. The low LTI/high FTI appears to be most associated with IDH. An optimal body composition for preventing the occurrence of IDH needs to be determined.

1.
Palmer BF, Henrich WL. Recent advances in the prevention and management of intradialytic hypotension.
J Am Soc Nephrol
. 2008 Jan;19(1):8–11.
2.
Davenport A. Intradialytic complications during hemodialysis.
Hemodial Int
. 2006 Apr;10(2):162–7.
3.
Donauer J. Hemodialysis-induced hypotension: impact of technologic advances.
Semin Dial
. 2004 Sep-Oct;17(5):333–5.
4.
Meredith DJ, Pugh CW, Sutherland S, Tarassenko L, Birks J. The relationship between symptoms and blood pressure during maintenance hemodialysis.
Hemodial Int
. 2015 Oct;19(4):543–52.
5.
Stefánsson BV, Brunelli SM, Cabrera C, Rosenbaum D, Anum E, Ramakrishnan K, et al. Intradialytic hypotension and risk of cardiovascular disease.
Clin J Am Soc Nephrol
. 2014 Dec;9(12):2124–32.
6.
Chang TI, Paik J, Greene T, Desai M, Bech F, Cheung AK, et al. Intradialytic hypotension and vascular access thrombosis.
J Am Soc Nephrol
. 2011 Aug;22(8):1526–33.
7.
Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function.
Clin J Am Soc Nephrol
. 2009 Dec;4(12):1925–31.
8.
Seong EY, Zheng Y, Winkelmayer WC, Montez-Rath ME, Chang TI. The Relationship between Intradialytic Hypotension and Hospitalized Mesenteric Ischemia: A Case-Control Study.
Clin J Am Soc Nephrol
. 2018 Oct;13(10):1517–25.
9.
Flythe JE, Xue H, Lynch KE, Curhan GC, Brunelli SM. Association of mortality risk with various definitions of intradialytic hypotension.
J Am Soc Nephrol
. 2015 Mar;26(3):724–34.
10.
Chou JA, Streja E, Nguyen DV, Rhee CM, Obi Y, Inrig JK, et al. Intradialytic hypotension, blood pressure changes and mortality risk in incident hemodialysis patients.
Nephrol Dial Transplant
. 2018 Jan;33(1):149–59.
11.
Chou JA, Kalantar-Zadeh K, Mathew AT. A brief review of intradialytic hypotension with a focus on survival.
Semin Dial
. 2017 Nov;30(6):473–80.
12.
Lai CT, Wu CJ, Chen HH, Pan CF, Chiang CL, Chang CY, et al. Absolute interdialytic weight gain is more important than percent weight gain for intradialytic hypotension in heavy patients.
Nephrology (Carlton)
. 2012 Mar;17(3):230–6.
13.
Sands JJ, Usvyat LA, Sullivan T, Segal JH, Zabetakis P, Kotanko P, et al. Intradialytic hypotension: frequency, sources of variation and correlation with clinical outcome.
Hemodial Int
. 2014 Apr;18(2):415–22.
14.
Broers NJ, Martens RJ, Cornelis T, Diederen NM, Wabel P, van der Sande FM, et al. Body composition in dialysis patients: a functional assessment of bioimpedance using different prediction models.
J Ren Nutr
. 2015 Mar;25(2):121–8.
15.
Huan-Sheng C, Yeong-Chang C, Ming-Hsing H, Fan-Lieh T, Chu-Cheng L, Tsai-Kun W, et al. Application of bioimpedance spectroscopy in Asian dialysis patients (ABISAD-III): a randomized controlled trial for clinical outcomes.
Int Urol Nephrol
. 2016 Nov;48(11):1897–909.
16.
Zhang H, Tao X, Shi L, Jiang N, Yang Y. Evaluation of body composition monitoring for assessment of nutritional status in hemodialysis patients.
Ren Fail
. 2019 Nov;41(1):377–83.
17.
Steyerberg EW, Eijkemans MJ, Harrell FE Jr, Habbema JD. Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets.
Med Decis Making
. 2001 Jan-Feb;21(1):45–56.
18.
Kuipers J, Verboom LM, Ipema KJ, Paans W, Krijnen WP, Gaillard CA, et al. The Prevalence of Intradialytic Hypotension in Patients on Conventional Hemodialysis: A Systematic Review with Meta-Analysis.
Am J Nephrol
. 2019;49(6):497–506.
19.
Lindley E, Keane D. Body composition monitoring: an emerging technology to help guide fluid management in haemodialysis patients.
J Ren Nurs
. 2014;6(2):59–64.
20.
Ribitsch W, Stockinger J, Schneditz D. Bioimpedance-based volume at clinical target weight is contracted in hemodialysis patients with a high body mass index.
Clin Nephrol
. 2012 May;77(5):376–82.
21.
Rosenberger J, Kissova V, Majernikova M, Straussova Z, Boldizsar J. Body composition monitor assessing malnutrition in the hemodialysis population independently predicts mortality.
J Ren Nutr
. 2014 May;24(3):172–6.
22.
Kalantar-Zadeh K, Kuwae N, Wu DY, Shantouf RS, Fouque D, Anker SD, et al. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients.
Am J Clin Nutr
. 2006 Feb;83(2):202–10.
23.
Beddhu S, Pappas LM, Ramkumar N, Samore M. Effects of body size and body composition on survival in hemodialysis patients.
J Am Soc Nephrol
. 2003 Sep;14(9):2366–72.
24.
Caetano C, Valente A, Oliveira T, Garagarza C. Body Composition and Mortality Predictors in Hemodialysis Patients.
J Ren Nutr
. 2016 Mar;26(2):81–6.
25.
Lin TY, Lim PS, Hung SC. Impact of Misclassification of Obesity by Body Mass Index on Mortality in Patients With CKD.
Kidney Int Rep
. 2017 Dec;3(2):447–55.
26.
Keane D, Gardiner C, Lindley E, Lines S, Woodrow G, Wright M. Changes in Body Composition in the Two Years after Initiation of Haemodialysis: A Retrospective Cohort Study.
Nutrients
. 2016 Nov;8(11):E702.
27.
Lin TY, Peng CH, Hung SC, Tarng DC. Body composition is associated with clinical outcomes in patients with non-dialysis-dependent chronic kidney disease.
Kidney Int
. 2018 Mar;93(3):733–40.
28.
Gonzalez MC, Pastore CA, Orlandi SP, Heymsfield SB. Obesity paradox in cancer: new insights provided by body composition.
Am J Clin Nutr
. 2014 May;99(5):999–1005.
29.
Lavie CJ, De Schutter A, Patel DA, Romero-Corral A, Artham SM, Milani RV. Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the “obesity paradox”.
J Am Coll Cardiol
. 2012 Oct;60(15):1374–80.
30.
Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, et al. Muscle wasting is associated with mortality in patients with cirrhosis.
Clin Gastroenterol Hepatol
. 2012 Feb;10(2):166–73.
31.
Postorino M, Marino C, Tripepi G, Zoccali C; CREDIT (Calabria Registry of Dialysis and Transplantation) Working Group. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease.
J Am Coll Cardiol
. 2009 Apr;53(15):1265–72.
32.
Kwan BC, Beddhu S. A story half untold: adiposity, adipokines and outcomes in dialysis population.
Semin Dial
. 2007 Nov-Dec;20(6):493–7.
33.
Pan WH, Lee MS, Chuang SY, Lin YC, Fu ML. Obesity pandemic, correlated factors and guidelines to define, screen and manage obesity in Taiwan.
Obes Rev
. 2008 Mar;9(s1 Suppl 1):22–31.
34.
Kuczmarski RJ, Flegal KM. Criteria for definition of overweight in transition: background and recommendations for the United States.
Am J Clin Nutr
. 2000 Nov;72(5):1074–81.
35.
Mc Causland FR, Waikar SS. Association of Predialysis Calculated Plasma Osmolarity With Intradialytic Blood Pressure Decline.
Am J Kidney Dis
. 2015 Sep;66(3):499–506.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.